Sensus Healthcare (SRTS) Return on Invested Capital (2022)
Sensus Healthcare's (SRTS) quarterly Return on Invested Capital came in at 33.15% in Q3 2022, down 140.12% quarter-over-quarter from 13.81% in Q2 2022.
Sensus Healthcare (SRTS) Return on Invested Capital (2022) Analysis & Trends
Sensus Healthcare's Return on Invested Capital history runs 1 years deep, the most recent figure standing at 33.15% for Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.01% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.01% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.01% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.00% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.00% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.00% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sensus Healthcare | 50.14 Mn | 31.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -33.15% |
| Jun 30, 2022 | -13.81% |
| Mar 31, 2022 | -8.30% |